Whether you’re new to comparative effectiveness research (CER) or an experienced imaging researcher who wants to take your research to the next level, RSNA’s new Value of Imaging through Comparative Effectiveness (VOICE) program is designed to help you achieve your goals. The program helps you learn the key methodologies you need to perform CER like decision analysis, systematic review and more. Led by a multi-institutional team of experienced faculty, this innovative nine-month interactive program uses a blended learning approach using:

• Hands-on training with two virtual workshops
• Web-based videos
• Webinars and readings
• Faculty support
• Extended access to course material

Click here to access the syllabus for the RSNA VOICE program. Though the online portion of the VOICE program is self-paced, and you may access the content in any order, the syllabus serves as a recommended guide on when to complete the online activities.

Click here to access the in-person workshop resource page.

Navigation Instructions:
Click ‘Launch’ and use the menu on the left to navigate through the self-paced activity. First, within the menu is the Overview page, which provides course, faculty, and CME information. Please click on “Pre-Test” and complete it by 11:59 PM Central February 24, 2022. After this date the Pre-Test will no longer be accessible online.

Select slide lectures from the workshop and online course will be made available after the in-person workshop. You will see a “Resources” tab added to the top right of your screen once these are available.

The webinar for this course will also be accessible from within the menu by April 22, 2022. Click on the Resources tab in the top-left to download the presentation slides after the live webinar.

To earn CME credit for this portion of the VOICE program, participants must correctly answer a minimum of 80% of the test questions and complete the Course Evaluation.

Learning Objectives:

• Explain principles and methods of comparative effectiveness research, including evidence synthesis and systematic review, decision analysis and cost effectiveness analysis.
• Use software programs for systematic review, decision analysis and cost-effectiveness analysis.
• Formulate key research questions that can be addressed using decision science methodology.
• Develop basic decision analytic models using TreeAge Pro Healthcare software.
• Summarize and interpret results of decision analytic models.

Content Areas (Codes):
The following Content Areas will be printed on the certificate for this course:

• Research and Statistical Methods

This  Other (enduring material) activity type is estimated to take 5 hours and 15 minutes to complete.

Start Date: 2/17/2022
End Date for CME Eligibility/Online Expiration Date: 2/16/2025

Faculty

• Stella Kang, MD, MSc 
• Pina C. Sanelli, MD, MPH
• Bart S. Ferket, MD, PhD
• Kathryn Lowry, MD

Disclosure Statements: 

RSNA controls the planning, development, and delivery of this CME activity and will strictly adhere to the Standards for Integrity and Independence in Accredited Continuing Education established by the Accreditation Council for Continuing Medical Education (ACCME).  

 

Listed below are all the financial disclosures provided by individuals in a position to influence and/or control CME activity content. All the financial relationships listed for these individuals have been mitigated. Please note that any individuals not listed below have reported no financial relationships (currently or within the past 24 months) with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. 

• Stella Kang, MD, MSc: Royalties, Wolters Kluwer NV.
• Pina C. Sanelli, MD: Investigator, Siemens AG; Research support, Siemens AG.
• Caroline Chung, MD, FRCPC: Research Support, Elekta AB; Research Support, RaySearch Laboratories AB; Research Support, Siemens AG.
• J. Brian Fowlkes, PhD: Research Grant, Koninklijke Philips NV; Equipment support, General Electric Company.
• Garry E. Gold, MD, MSEE: Research support, General Electric Company.
• Safwan Halabi, MD: Chief Medical Officer, Interfierce; Stockholder, DNAFeed; Adviser, Bunker Hill.
• Udo Hoffmann, MD: Research Grant, Kowa Company, Ltd; Research Grant, Abbott Laboratories; Research Grant, HeartFlow, Inc; Research Grant, AstraZeneca PLC.
• Jeffrey G. Jarvik, MD: Author with royalties, Wolters Kluwer nv; Co editor, Springer Nature; Royalties, Springer Nature.
• Mitchell Machtay, MD: Advisory Board, AstraZeneca PLC; Research Grant, AstraZeneca PLC; Speaker, AstraZeneca PLC; Consultant, ElektaAB; Travel Support, ElektaAB; Consultant, Varian Medical Systems, Inc; Travel Support, Varian Medical Systems, Inc; Consultant, ViewRay, Inc; Travel Support, ViewRay, Inc.
• Satoshi Minoshima, MD, PhD: Consultant, Hamamatsu Photonics KK; Research Grant, Hitachi, Ltd; Research Grant, Nihon Medi Physics Co, Ltd.
• Aytekin Oto, MD: Research Grant, Koninklijke Philips NV; Research Grant, Guerbet SA; Research Grant, Profound Medical Inc; Medical Advisory Board, Profound Medical Inc; Consultant, IBM Corporation; Founder and co owner, QMIS TBS Capital Group Corp.
• Martin G. Pomper, MD, PhD: Co founder, CSO; Co founder, D&D Pharmatech; Research support, D&D Pharmatech; Stockholder, D&D Pharmatech; Royalties, D&D Pharmatech; Royalties, Intuitive Surgical, Inc; Research support, Progenics Pharmaceuticals, Inc; Research support, Novartis AG; Royalties, Novartis AG.
• Rebecca Rakow-Penner, MD, PhD: Research Grant, General Electric Company; Researcher, General Electric Company.
• Kathryn Lowry, MD: Research grant, General Electric Co.

Accreditation and Designation Statements: 

The Radiological Society of North America (RSNA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

To earn CME credit, participants must correctly answer a minimum of 80% of the post-test questions and complete the course evaluation. 

The RSNA designates this Other (enduring material) activity type for a maximum of 5.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The opinions or views expressed in this activity are those of the presenters and do not necessarily reflect the opinions, recommendations or endorsement of the RSNA. Participants should critically appraise the information presented and are encouraged to consult appropriate resources for information surrounding any product or device mentioned. Information presented, as well as publications, technologies, products and/or services discussed, are intended to inform the learner about the knowledge, techniques, and experiences of RSNA faculty who are willing to share such information with colleagues. The RSNA disclaims any and all liability for damages to any individual user for all claims which may result from the use of said information, publications, technologies, products and/or services, and events.